Efmody 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
PSUSA/9176/
Periodic Safety Update EU Single assessment - 
22/06/2023 
23/08/2023 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
202211 
hydrocortisone (for centrally authorised products for 
the variation to terms of the Marketing Authorisation(s)’ for 
adrenal insufficiency, congenital adrenal hyperplasia, 
PSUSA/9176/202211. 
modified-release formulations) 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
IB/0004/G 
This was an application for a group of variations. 
21/06/2022 
29/06/2023 
SmPC, 
B.II.e.5.a.2 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
B.II.e.5.a.2 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
Labelling and 
PL 
IA/0002 
B.II.b.5.b - Change to in-process tests or limits 
10/05/2022 
n/a 
applied during the manufacture of the finished 
product - Addition of a new test(s) and limits 
IAIN/0001/G 
This was an application for a group of variations. 
08/06/2021 
08/07/2022 
SmPC, Annex 
II and PL 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.1.b - Replacement or addition of a 
manufacturing site for the FP - Primary packaging 
site 
Page 2/2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
